Madrigal Pharmaceuticals logo

Sr Director, Field Medical Strategy & Execution

Madrigal Pharmaceuticals

Conshohocken, PAOnsitePosted 1 day ago$288,001 - $352,001 per year
Full TimeDirector & AboveMedical AffairsPharmaceutical
Original posting ↗

Summary

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH). The Sr Director, Field Medical Strategy & Execution is a senior leadership role responsible for translating Medical Affairs scientific strategy into coordinated, actionable Field Medical initiatives that drive meaningful scientific engagement, organizational effectiveness, and assess impact of Field Medical work.

Job description

Key Responsibilities

Field Medical Strategy & Execution

  • Partner with the Vice President, Field Medical and FMLT to support the development and execution of Field Medical strategic priorities aligned with Medical Affairs objectives.
  • Translate scientific priorities into actionable field initiatives with clear objectives, accountable owners, milestones, and measures of success.
  • Lead a defined portfolio of high-priority, cross-functional Field Medical initiatives from planning through implementation and evaluation.
  • Identify execution gaps, dependencies, and barriers; collaborate with accountable leaders to resolve them and adjust approaches as needed.
  • Coordinate implementation across GI/Hepatology MSL, Endocrinology MSL, CPL, and Health Systems functions while respecting their distinct roles.
  • Assess the effectiveness of initiatives and recommend changes that improve scientific engagement and organizational impact.

Medical Strategy Alignment & Cross-Functional Integration

  • Serve as a strategic connection between Field Medical leadership and Headquarters Medical Affairs, supporting bidirectional alignment of priorities and execution.
  • Partner with Medical Directors and Medical Strategy leads to translate emerging evidence and scientific priorities into field engagement approaches.
  • Bring field perspectives into Medical Affairs strategic and tactical planning and support integrated initiatives with Scientific Communications, Medical Education, HEOR/RWE, and Clinical Development.
  • Advance coordinated scientific engagement approaches across complex healthcare systems and stakeholder groups.
  • Maintain Medical Affairs independence and comply with applicable governance requirements in cross-functional collaboration.

Field Insights & Strategic Intelligence

  • Lead the strategic synthesis and interpretation of field-generated scientific insights, emerging clinical trends, stakeholder perspectives, and unmet medical needs.
  • Partner with Field Medical leaders and Medical Operations to distinguish meaningful patterns from isolated observations.
  • Convert insights into actionable recommendations for medical strategy, evidence generation, education, resources, and stakeholder engagement.
  • Present executive-level scientific themes, implications, and recommended actions to Medical Affairs leadership.
  • Close the feedback loop by helping field teams understand how insights influenced decisions and priorities.

Field Medical Effectiveness & Impact

  • Partner with Field Medical leaders to define measures of strategic execution, scientific engagement effectiveness, and organizational impact.
  • Evaluate progress against strategic priorities, identify gaps, and recommend targeted improvements.
  • Interpret standardized data and reporting produced by Medical Operations to identify trends and opportunities; do not own dashboard or CRM infrastructure.
  • Assessment of impact field activities to include both quantitative and qualitative measures including quality of scientific exchange, collaborative work with cross functional partners, and impact that improves patient care.
  • Develop compelling executive narratives demonstrating the scientific and organizational value of Field Medical.

FMLT Leadership & Strategic Initiatives

  • Serve as an active FMLT member and trusted strategic advisor to the Vice President, Field Medical.
  • Lead designated high-priority strategic initiatives requiring coordination across Field Medical functions and HQ partners.
  • Facilitate leadership alignment on priorities, critical decisions, execution commitments, and measurable outcomes.
  • Identify and scale effective scientific engagement practices and support organizational change initiatives.
  • Represent Field Medical on selected cross-functional strategic workstreams as delegated by the Vice President.

Qualifications

Education & Experience

  • Advanced scientific or healthcare degree strongly preferred (PharmD, PhD, or equivalent)
  • 15+ years of pharmaceutical or biotechnology industry experience, including significant Medical Affairs experience.
  • Significant Field Medical experience strongly preferred, including understanding of MSL/CPL and other Field Medical roles.
  • Demonstrated success leading strategic initiatives, influencing senior stakeholders in a matrixed organization, and translating strategy into measurable outcomes.
  • Experience collaborating with Medical Strategy, Clinical Development, Medical Operations, and other Medical Affairs functions.

Skills & Capabilities

  • Demonstrates strong executive presence, sound judgment, and exceptional communication skills, with the ability to engage and influence senior leadership, articulate complex strategic priorities with clarity and confidence, and build credibility across a highly matrixed organization.
  • Strong scientific and strategic judgment, with the ability to translate complex priorities into executable initiatives.
  • Excellent cross-functional leadership, influence without direct authority, and executive communication skills.
  • Ability to synthesize qualitative and quantitative scientific insights into actionable recommendations.
  • Strong program leadership, prioritization, change leadership, and outcome evaluation capabilities.
  • Working knowledge of Field Medical engagement, insights, performance measurement, and relevant analytics; familiarity with Veeva and reporting tools is beneficial but not a primary job responsibility.
  • Strong understanding of pharmaceutical legal, regulatory, and compliance requirements governing Medical Affairs and scientific exchange.

Requirements

  • Advanced scientific or healthcare degree strongly preferred (PharmD, PhD, or equivalent)
  • 15+ years of pharmaceutical or biotechnology industry experience, including significant Medical Affairs experience
  • Significant Field Medical experience strongly preferred, including understanding of MSL/CPL and other Field Medical roles
  • Demonstrated success leading strategic initiatives, influencing senior stakeholders in a matrixed organization, and translating strategy into measurable outcomes
  • Experience collaborating with Medical Strategy, Clinical Development, Medical Operations, and other Medical Affairs functions
  • Strong executive presence, sound judgment, and exceptional communication skills
  • Strong scientific and strategic judgment
  • Excellent cross-functional leadership, influence without direct authority, and executive communication skills
  • Ability to synthesize qualitative and quantitative scientific insights into actionable recommendations
  • Strong program leadership, prioritization, change leadership, and outcome evaluation capabilities
  • Working knowledge of Field Medical engagement, insights, performance measurement, and relevant analytics
  • Familiarity with Veeva and reporting tools is beneficial
  • Strong understanding of pharmaceutical legal, regulatory, and compliance requirements governing Medical Affairs and scientific exchange

Benefits

  • Flexible PTO
  • Medical, Dental & Vision
  • Life & Disability Insurance
  • 401(k) with Employer Match
  • Equity
  • Mental Health Benefits
  • Employee Assistance Program
  • Supplemental Life Insurance
  • Legal Services

Company overview

Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), formerly known as non-alcoholic steatohepatitis (NASH), a serious form of fatty liver disease. The company's lead product, Rezdiffra (resmetirom), is a once-daily, oral thyroid hormone receptor (THR)-β selective agonist that targets key underlying causes of MASH in the liver. Rezdiffra received FDA approval in 2024 as the first treatment for MASH with moderate to advanced liver fibrosis, representing a significant breakthrough in hepatology. Headquartered in Conshohocken, Pennsylvania, Madrigal is publicly traded on NASDAQ under the symbol MDGL. The company continues to advance its clinical development programs, including ongoing Phase 3 trials evaluating Rezdiffra for the treatment of compensated MASH cirrhosis. Madrigal's innovative approach addresses a critical unmet medical need in liver disease therapeutics.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.